Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CoheroHealth
The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes:
1. HeroTracker sensor that counts dosage and monitors real-time medication adherence
2. BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ability to provide written informed consent
Male and female adults (aged ≥ 18 years)
Diagnosis of asthma for at least 6 months
ICS (inhaled corticosteroid) use for at least 3 months
Use of a pressurized metered dose inhaler (pMDI) compatible with the HeroTracker
Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher)
You may not be if
Currently pregnant or planning to become pregnant during the study period
Primary language other than English (BreatheSmart mobile app is currently available only in English)
Clareo Health | Assessing the Use of Mobile Technology in Adult Asthma Patients
